Company / Current Assets
ABEONA THERAPEUTICS INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$204.9M
FY2025
5-year range
$53.1M / $204.9M
FY2021-FY2025
Trend
+103.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has increased for 3 consecutive years, from $53M in FY2022 to $205M in FY2025.
Based on SEC 10-K filings.
$205M in FY2025 with a 5-year CAGR of +16.0%.
Improved from $56M to $205M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +56.9%
- 5-Year CAGR
- +16.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- ABEONA THERAPEUTICS INC.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +16.0%, indicating consistent growth.
- In FY2025, current assets increased 103.2% year-over-year.
- Lowest current assets in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $204.9M | +103.2% |
| FY2024 | $100.9M | +80.9% |
| FY2023 | $55.7M | +5.0% |
| FY2022 | $53.1M | -4.2% |
| FY2021 | $55.4M | -43.3% |
| FY2020 | $97.7M | -26.2% |
| FY2019 | $132.4M | +49.0% |
| FY2018 | $88.9M | -36.8% |
| FY2017 | $140.6M | +102.5% |
| FY2016 | $69.4M | +71.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026